Segment Information (Tables)

6 Months Ended

Jun. 30, 2025

Segment Information [Abstract]

Schedule of Segment Information

		During the Three-Month Period Ended June 30, 2025
		Scours				Mastitis				Other				Total
Product sales		$	6,398,517			$	46,363			$	—			$	6,444,880
Costs of goods sold			3,589,893				37,063				—				3,626,956
Gross margin			2,808,624				9,300				—				2,817,924

Product development expenses			93,011				710,745				28,102				831,858
Sales and marketing expenses			634,846				61,240				—				696,086
Administrative expenses			—				—				720,418				720,418
Operating expenses			727,857				771,985				748,520				2,248,362

NET OPERATING INCOME (LOSS)		$	2,080,767			$	(762,685	)		$	(748,520	)		$	569,562

		During the Three-Month Period Ended June 30, 2024
		Scours				Mastitis				Other				Total
Product sales		$	5,430,069			$	42,821			$	—			$	5,472,890
Costs of goods sold			4,198,849				43,555				—				4,242,404
Gross margin			1,231,220				(734	)			—				1,230,486

Product development expenses			65,598				928,531				36,373				1,030,502
Sales and marketing expenses			855,513				129,444				—				984,957
Administrative expenses			—				—				601,634				601,634
Operating expenses			921,111				1,057,975				638,007				2,617,093

NET OPERATING INCOME (LOSS)		$	310,109			$	(1,058,709	)		$	(638,007	)		$	(1,386,607	)

		Scours				Mastitis				Other				Total
Total Assets as of June 30, 2025		$	24,612,357			$	15,924,755			$	6,183,786			$	46,720,898
Total Assets as of June 30, 2024		$	23,240,545			$	17,107,377			$	1,507,536			$	41,855,458
Depreciation and amortization expense during the three-month period ended June 30, 2025		$	345,512			$	314,175			$	19,350			$	679,037
Depreciation and amortization expense during the three-month period ended June 30, 2024		$	342,362			$	319,727			$	19,676			$	681,765
Capital Expenditures during the three-month period ended June 30, 2025		$	151,808			$	1,079			$	2,271			$	155,158
Capital Expenditures during the three month period ended June 30, 2024		$	93,338			$	17,403			$	—			$	110,741

		During the Six-Month Period Ended June 30, 2025
		Scours				Mastitis				Other				Total
Product sales		$	14,427,003			$	85,051			$	—			$	14,512,054
Costs of goods sold			8,264,436				75,722				—				8,340,158
Gross margin			6,162,567				9,329				—				6,171,896

Product development expenses			186,496				1,339,657				62,552				1,588,705
Sales and marketing expenses			1,421,983				130,761				—				1,552,744
Administrative expenses			—				—				1,343,260				1,343,260
Operating expenses			1,608,479				1,470,418				1,405,812				4,484,709

NET OPERATING INCOME (LOSS)		$	4,554,088			$	(1,461,089	)		$	(1,405,812	)		$	1,687,187

		During the Six-Month Period Ended June 30, 2024
		Scours				Mastitis				Other				Total
Product sales		$	12,650,710			$	79,757			$	—			$	12,730,467
Costs of goods sold			9,122,397				82,225				—				9,204,622
Gross margin			3,528,313				(2,468	)			—				3,525,845

Product development expenses			95,093				2,131,473				66,487				2,293,053
Sales and marketing expenses			1,525,252				260,628				—				1,785,880
Administrative expenses			—				—				1,133,572				1,133,572
Operating expenses			1,620,345				2,392,101				1,200,059				5,212,505

NET OPERATING INCOME (LOSS)		$	1,907,968			$	(2,394,569	)		$	(1,200,059	)		$	(1,686,660	)

		Scours				Mastitis				Other				Total
Total Assets as of June 30, 2025		$	24,612,357			$	15,924,755			$	6,183,786			$	46,720,898
Total Assets as of June 30, 2024		$	23,240,545			$	17,107,377			$	1,507,536			$	41,855,458
Depreciation and amortization expense during the six-month period ended June 30, 2025		$	698,034			$	628,834			$	38,942			$	1,365,810
Depreciation and amortization expense during the six-month period ended June 30, 2024		$	681,281			$	638,445			$	39,539			$	1,359,265
Capital Expenditures during the six-month period ended June 30, 2025		$	474,185			$	7,752			$	2,271			$	484,208
Capital Expenditures during the six-month period ended June 30, 2024		$	132,812			$	48,285			$	—			$	181,097